Skip to main content
Clinical Trials/DRKS00028707
DRKS00028707RecruitingNot Applicable

Evaluation of Transplant-reactive T cells for the Prediction or Diagnosis of Transplant Rejection in Kidney Transplant Recipients (TreaT-Assay) - TreaT-Assay

Charité Campus Virchow-Klinikum0 sites185 target enrollmentStarted: April 27, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
185

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to 110 Years (—)
Sex
All

Inclusion Criteria

  • Condition after kidney transplant or non-kidney transplant control
  • - Deterioration of transplant function and indication for renal transplant biopsy
  • - Signed informed consent form
  • - Age >18 years
  • - Existing health insurance

Exclusion Criteria

  • - Age under 18 years
  • - Lack of capacity to give consent
  • - Lack of written informed consent
  • - viral infections such as hepatitis B, hepatitis C or/and HIV

Investigators

Sponsor
Charité Campus Virchow-Klinikum

Similar Trials